The metabolism of 3, 5-[3'-125I] triiodothyronin (T3) and 3-[3', 5'-125I] triiodothyronine (rT3) was studied in cultured monkey hepatocarcinoma cells (NCLP-6E), and the deiodinations of these iodothyronines were also investigated in cultured cell homogenates and in rat liver homogenates.
(T3) and 3-[3', 5'-125I] triiodothyronine (rT3) was studied in cultured monkey hepatocarcinoma cells (NCLP-6E), and the deiodinations of these iodothyronines were also investigated in cultured cell homogenates and in rat liver homogenates.
The metabolites were analyzed by ionexchange column chromatography.
For nonphenolic ring deiodination of 3, 5-[3'-125I] triiodothyronine, the order of the inhibitory effect of excess unlabeled iodothyronine or its analog was as follows: 3, 3', 5-tiiodothyronine>triiodothyroacetic acid>tetraiodothyroacetic acid> thyroxine.
This order did not differ between in the intact cells (NCLP-6E) and their homogenates. It is a current theory that 3, 3', 5-triiodothyronine (T3) and 3, 3', 5'-triiodothyronine (rT3) are mainly formed by the extrathyroidal deiodinations of thyroxine (T4). In the metabolism of T4, when monodeiodinations occur in the phenolic and nonphenolic rings of thyroxine, T3 and rT3, respectively, are formed. The formation of T3 means the activation of T4, and that of rT3, the inactivation.
In vivo experiments (Pittman and Barker, 1959a, 1959b; Benua et al., 1959) showed that rT3 behaved as an antagonist of the thyroid hormones.
Recently, Coiro et al. (1980) investigated the exact effect of rT3 on the conversion of T4 to T3 in vivo, and the same subject was studied in cultured monkey hepatocarcinoma cells (Sorimachi, 1980) . These results and other data obtained from the experiments utilizing cell homogenates (Sorimachi and Robbins, 1979; Sorimachi et al., 1980a) and tissue homogenates (Chopra, 1977; Kaplan and Utiger, 1978; Visser et al., 1979) revealed that rT3 has particularly high affinity for phenolic ring deiodinase among the thyroid hormones and their analogs.
